XML 49 R24.htm IDEA: XBRL DOCUMENT
v3.24.0.1

IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS | 12 Months Ended
--- | ---
Dec. 31, 2023
Impairment or Disposal of Tangible Assets Disclosure [Abstract] |
IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS | 12. IMPAIRMENT OF LONG-LIVED AND OTHER ASSETS The Company reviews for impairment indicators related to its long-lived assets on a quarterly basis and goodwill on an annual basis or whenever events or changes in circumstances indicate the carrying amount of those assets may not be fully recoverable. The Company performed a quantitative impairment analysis on its goodwill, tradename intangible assets and other long-lived assets, including theatre properties and right-of-use assets, as of December 31, 2023. See Note 1 for a discussion of the Company’s impairment policy and a description of qualitative and quantitative impairment assessments. Below is a summary of impairment charges for the periods indicated:
|  | Year Ended
|  | December 31,
|  | 2021 |  | 2022 |  | 2023
U.S. segment |  |  |  |  |  |
Theatre properties |  | $6.4 |  | $19.7 |  | $6.6
Theatre operating lease right-of-use assets |  | 6.8 |  | 34.0 |  | 7.1
Investment in NCM (1) |  | — |  | 113.2 |  | 0.7
Other |  | — |  | 3.9 |  | —
U.S. total |  | 13.2 |  | 170.8 |  | 14.4
International segment |  |  |  |  |  |
Theatre properties |  | 4.0 |  | 2.2 |  | 0.7
Theatre operating lease right-of-use assets |  | 3.2 |  | 1.1 |  | 1.5
Intangible assets, net |  | 0.4 |  | — |  | —
International total |  | 7.6 |  | 3.3 |  | 2.2
Total impairment |  | $20.8 |  | $174.1 |  | $16.6
(1) See discussion at Investment in National CineMedia in Note 9. For the years ended December 31, 2021, 2022 and 2023, impairment charges were primarily due to the unprecedented impact of the COVID-19 pandemic on the theatrical exhibition industry and its ongoing recovery, as discussed in Note 3.

X
- Definition The entire disclosure for the details of the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value. Disclosure may also include a description of the impaired asset and facts and circumstances leading to the impairment, amount of the impairment loss and where the loss is located in the income statement, method(s) for determining fair value, and the segment in which the impaired asset is reported. + References No definition available. + Details
Name: | us-gaap_AssetImpairmentChargesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_ImpairmentOrDisposalOfTangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration